XBiotech Inc. (XBIT): Net Income
-$45.54M
Year ended 2025-12-31
-$45.13M
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$45.54M | n/m | 2026-03-13, From 2025-01-01 |
| 2024-12-31 | -$38.53M | n/m | 2026-03-13, From 2024-01-01 |
| 2023-12-31 | -$24.56M | n/m | 2025-03-18, From 2023-01-01 |
| 2022-12-31 | -$32.90M | n/m | 2024-03-15, From 2022-01-01 |
| 2021-12-31 | -$17.41M | n/m | 2023-03-15, From 2021-01-01 |
| 2020-12-31 | -$11.22M | n/m | 2022-03-15, From 2020-01-01 |
| 2019-12-31 | $668.63M | n/m | 2022-03-15, From 2019-01-01 |
| 2018-12-31 | -$21.14M | n/m | 2021-03-16, From 2018-01-01 |
| 2017-12-31 | -$33.15M | n/m | 2020-03-16, From 2017-01-01 |
| 2016-12-31 | -$52.76M | n/m | 2019-03-15, From 2016-01-01 |
| 2015-12-31 | -$37.48M | n/m | 2018-03-16, From 2015-01-01 |
| 2014-12-31 | -$21.72M | n/m | 2017-03-16, From 2014-01-01 |
| 2013-12-31 | -$9.93M | n/a | 2016-04-15, From 2013-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| XBiotech Inc. (XBIT) | 2025-12-31 | -$45.54M | n/m |
| Whitehawk Therapeutics, Inc. (WHWK) | 2025-12-31 | -$20.60M | n/m |
| Ovid Therapeutics Inc. (OVID) | 2025-12-31 | -$17.41M | n/m |
| CytomX Therapeutics, Inc. (CTMX) | 2025-12-31 | -$17.37M | n/m |
| Veradermics, Inc (MANE) | 2025-12-31 | -$70.00M | n/m |
| Larimar Therapeutics, Inc. (LRMR) | 2025-12-31 | -$165.67M | n/m |
| Xilio Therapeutics, Inc. (XLO) | 2025-12-31 | -$35.04M | n/m |
| Precigen, Inc. (PGEN) | 2025-12-31 | -$250.64M | n/m |
| Boundless Bio, Inc. (BOLD) | 2025-12-31 | -$58.20M | n/m |
Compare XBIT, WHWK, OVID, CTMX side by side · Screen every company in Pharmaceutical Preparations ↗